Instil Bio (TIL) Share-based Compensation (2020 - 2026)

Instil Bio has reported Share-based Compensation for 7 years, with the latest figure at $1.2 million in Q2 2026.

• On a quarterly basis, Share-based Compensation fell 32.68% year-over-year to $1.2 million in Q2 2026; TTM through Jun 2026 was $5.6 million, a 59.77% decrease from a year earlier, with the FY2025 full-year figure at $8.7 million, down 49.63% from the prior year.
• Share-based Compensation was $1.2 million for Q2 2026 at Instil Bio, up from $985000.0 in the prior quarter.
• The five-year high for Share-based Compensation was $8.3 million in Q2 2022, with the low at $985000.0 in Q1 2026.
• Average Share-based Compensation over 5 years is $4.3 million, with a median of $4.5 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Share-based Compensation surged 166.47% in 2022, then sank 71.82% in 2026.
• Over 5 years, Share-based Compensation stood at $6.6 million in 2022, then tumbled by 31.46% to $4.6 million in 2023, then retreated by 1.14% to $4.5 million in 2024, then plunged by 64.32% to $1.6 million in 2025, then decreased by 23.54% to $1.2 million in 2026.
• The last three Share-based Compensation figures came in at $1.2 million (Q2 2026), $985000.0 (Q1 2026), and $1.6 million (Q4 2025), per Business Quant data.